Therapeutic Patient Education for Adrenal Insufficiency under COVID-19 Pandemic Conditions

Abstract

Adrenal insufficiency (AI) requires life-long treatment with glucocorticoid replacement therapy. Over- or under-substitution carries the risk of increased morbidity in the form of side effects or adrenal crises. Glucocorticoid replacement therapy needs to be flexible with dose adaptation in special situations. This could not be managed by medical personnel on a daily basis, but requires an educated patient who has a good knowledge of the disease, understands his medical therapy and is able to perform situational dose adaptation. The rarity of the disease in combination with the need to respond to stressful situations with rapid glucocorticoid dose adjustment underlines that a well-trained patient is crucial for optimal management of the disease.

In this literature review we provide background information further clarifying the need of education in patients with AI including the current shortcomings of medical therapy and of the treatment of patients with AI. We outline the aims of therapeutic patient education, present the concept of structured patient education in Germany, and discuss available results of patient group education programs. Furthermore, we propose strategies how therapeutic patient education for adrenal insufficiency can be organized under COVID-19 pandemic conditions.

Key words

adrenal crisis - hydrocortisone - secondary adrenal insufficiency - emergency card

Publication History

Received: 27 March 2020
Received: 25 June 2020

Accepted: 08 July 2020

Article published online:
06 August 2020

• References

• 1 Erichsen MM, Lovas K, Skinningsrud B. et al. Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 2009; 94: 4882-90 Epub 2009/10/28. DOI: 10.1210/jc.2009-1368 PubMed PMID: 19858318.
• 2 Burman P, Mattsson AF, Johannsson G. et al. Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J Clin Endocrinol Metab 2013; 98: 1466-75 Epub 2013/03/05 DOI: 10.1210/jc.2012-4059. PubMed PMID: 23457412.
• 3 Sherlock M, Ayuk J, Tomlinson JW. et al. Mortality in patients with pituitary disease. Endocr Rev. 2010; 31: 301-42 Epub 2010/01/21 DOI: 10.1210/er.2009-0033 PubMed PMID: 20086217.
• 4 Bensing S, Brandt L, Tabaroj F. et al. Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin Endocrinol (Oxf) 2008; 69: 697-704 Epub 2008/08/30 DOI: 10.1111/j.1365-2265.2008.03340.x PubMed PMID: 18727712.
• 5 Falhammar H, Frisen L, Norrby C. et al. Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2014; 99: E2715-21 Epub 2014/10/04 DOI: 10.1210/jc.2014-2957 PubMed PMID: 25279502.
• 6 Bergthorsdottir R, Leonsson-Zachrisson M, Oden A. et al. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab 2006; 91: 4849-53 Epub 2006/09/14. DOI: 10.1210/jc.2006-0076. PubMed PMID: 16968806.
• 7 Smans LC, Souverein PC, Leufkens HG. et al. Increased use of antimicrobial agents and hospital admission for infections in patients with primary adrenal insufficiency: a cohort study. Eur J Endocrinol 2013; 168: 609-14. Epub 2013/02/07 DOI: 10.1530/eje-12-0879. PubMed PMID: 23384710.
• 8 Mebrahtu TF, Morgan AW, Keeley A. et al. Dose dependency of iatrogenic glucocorticoid excess and adrenal insufficiency and mortality: a cohort study in England. J Clin Endocrinol Metab 2019; Epub 2019/04/23 DOI: 10.1210/jc.2019-00153 PubMed PMID: 31009052; PubMed Central PMCID: PMCPMC6656418.
• 9 Sherlock M, Reulen RC, Alonso AA. et al. ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab 2009; 94: 4216-23 Epub 2009/10/08 DOI: 10.1210/jc.2009-1097. PubMed PMID: 19808848.
• 10 Zueger T, Kirchner P, Herren C. et al. Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma. J Clin Endocrinol Metab 2012; 97: E1938-42 Epub 2012/08/09 DOI: 10.1210/jc.2012-2432 PubMed PMID: 22872686.
• 11 Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990; 336: 285-8 Epub 1990/08/04. DOI: 10.1016/0140-6736(90)91812-o PubMed PMID: 1973979.
• 12 Clayton RN, Jones PW, Reulen RC. et al. Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. Lancet Diabetes Endocrinol. 2016; 4(7):569-76. Epub 2016/06/0 7 DOI: 10.1016/s2213-8587(16)30005-5 PubMed PMID: 27265184.
• 13 Quinkler M, Ekman B, Zhang P. et al. Mortality data from the European Adrenal Insufficiency Registry-Patient characterization and associations. Clin Endocrinol (Oxf) 2018; 89: 30-5 Epub 2018/04/24. DOI: 10.1111/cen.13609 PubMed PMID: 29682773.
• 14 Behan LA, Carmody D, Rogers B. et al. Low-dose hydrocortisone replacement is associated with improved arterial stiffness index and blood pressure dynamics in severely adrenocorticotrophin-deficient hypopituitary male patients. Eur J Endocrinol 2016; 174: 791-9 Epub 2016/03/31 DOI: 10.1530/eje-15-1187. PubMed PMID: 27025241.
• 15 Werumeus Buning J, van Faassen M, Brummelman P. et al. Effects of Hydrocortisone on the Regulation of Blood Pressure: Results From a Randomized Controlled Trial. J Clin Endocrinol Metab 2016; 101: 3691-9 Epub 2016/08/05. DOI: 10.1210/jc.2016-2216 PubMed PMID: 27490921.
• 16 Allolio B, Lang K, Hahner S. Addisonian crisis in a young man with atypical anorexia nervosa. Nat Rev Endocrinol 2011; 7: 115-21. Epub 2010/12/24 DOI: 10.1038/nrendo.2010.211 PubMed PMID: 21178996.
• 17 White K, Arlt W. Adrenal crisis in treated Addison's disease: a predictable but under-managed event. Eur J Endocrinol 2010; 162: 115-20. Epub 2009/09/25 DOI: 10.1530/eje-09-0559. PubMed PMID: 19776201.
• 18 Hahner S, Loeffler M, Bleicken B. et al. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol 2010; 162: 597-602 Epub 2009/12/04. DOI: 10.1530/eje-09-0884. PubMed PMID: 19955259.
• 19 Omori K, Nomura K, Shimizu S. et al. Risk factors for adrenal crisis in patients with adrenal insufficiency. Endocr J. 2003; 50: 745-52 Epub 2004/01/08 DOI: 10.1507/endocrj.50.745 PubMed PMID: 14709847.
• 20 Reisch N, Willige M, Kohn D. et al. Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. Eur J Endocrinol 2012; 167: 35-42 Epub 2012/04/20 DOI: 10.1530/eje-12-0161. PubMed PMID: 22513882.
• 21 Allolio B. Extensive expertise in endocrinology. Adrenal crisis. Eur J Endocrinol 2015; 172: R115-24. Epub 2014/10/08 DOI: 10.1530/eje-14-0824 PubMed PMID: 25288693.
• 22 Hahner S, Spinnler C, Fassnacht M. et al. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab 2015; 100: 407-16. Epub 2014/11/25 DOI: 10.1210/jc.2014-3191 PubMed PMID: 25419882.
• 23 Husebye ES, Allolio B, Arlt W. et al. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 2014; 275: 104-15 Epub 2013/12/18. DOI: 10.1111/joim.12162.PubMed PMID: 24330030.
• 24 Grossman A, Johannsson G, Quinkler M. et al. Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe. Eur J Endocrinol 2013; 169: R165-75 Epub 2013/09/14 DOI: 10.1530/eje-13-0450 PubMed PMID: 24031090; PubMed Central PMCID: PMCPMC3805018.
• 25 Murray RD, Ekman B, Uddin S. et al. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR. Clin Endocrinol (Oxf) 2017; 86: 340-6 Epub 2016/11/02 DOI: 10.1111/cen.13267 PubMed PMID: 27801983.
• 26 Bornstein SR, Allolio B, Arlt W. et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101: 364-89 Epub 2016/01/14. DOI: 10.1210/jc.2015-1710 PubMed PMID: 26760044; PubMed Central PMCID: PMCPMC4880116.
• 27 Esteban NV, Loughlin T, Yergey AL. et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 1991; 72: 39-45 Epub 1991/01/01 DOI: 10.1210/jcem-72-1-39 PubMed PMID: 1986026.
• 28 Mah PM, Jenkins RC, Rostami-Hodjegan A. et al. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 2004; 61: 367-75 Epub 2004/09/10. DOI: 10.1111/j.1365-2265.2004.02106.x PubMed PMID: 15355454.
• 29 Weise M, Drinkard B, Mehlinger SL. et al. Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise. J Clin Endocrinol Metab 2004; 89: 3679-84 Epub 2004/08/05. DOI: 10.1210/jc.2003-032051 PubMed PMID: 15292287.
• 30 Simunkova K, Jovanovic N, Rostrup E. et al. Effect of a pre-exercise hydrocortisone dose on short-term physical performance in female patients with primary adrenal failure. Eur J Endocrinol 2016; 174: 97-105. Epub 2015/10/24 DOI: 10.1530/eje-15-0630. PubMed PMID: 26494876.
• 31 Quinkler M, Hahner S. What is the best long-term management strategy for patients with primary adrenal insufficiency?. Clin Endocrinol (Oxf) 2012; 76: 21-5 Epub 2011/05/19 DOI: 10.1111/j.1365-2265.2011.04103.x PubMed PMID: 21585418.
• 32 Quinkler M, Beuschlein F, Hahner S. et al. Adrenal cortical insufficiency--a life threatening illness with multiple etiologies. Dtsch Arztebl Int 2013; 110(51-52): 882-8 Epub 2014/02/18. DOI: 10.3238/arztebl.2013.0882 PubMed PMID: 24529304; PubMed Central PMCID: PMCPMC3928535.
• 33 Quinkler M, Hahner S, Johannsson G. et al. Saving lives of patients with adrenal insufficiency: a pan-European initiative?. Clin Endocrinol (Oxf) 2014; 80: 319-21. Epub 2013/12/05. DOI: 10.1111/cen.12378 PubMed PMID: 24299429.
• 34 Quinkler M, Dahlqvist P, Husebye ES. et al. A European Emergency Card for adrenal insufficiency can save lives. Eur J Intern Med 2015; 26: 75-6 Epub 2014/12/17. DOI: 10.1016/j.ejim.2014.11.006 PubMed PMID: 25498511.
• 35 Petersenn S, Honegger J, Quinkler M. National German Audit of Diagnosis, Treatment, and Teaching in Secondary Adrenal Insufficiency. Horm Metab Res 2017; 49: 580-8 Epub 2017/03/30 DOI: 10.1055/s-0043-105077 PubMed PMID: 28351092.
• 36 Hahner S, Hemmelmann N, Quinkler M. et al. Timelines in the management of adrenal crisis - targets, limits and reality. Clin Endocrinol (Oxf) 2015; 82: 497-502 Epub 2014/09/10 DOI: 10.1111/cen.12609 PubMed PMID: 25200922.
• 37 Burger-Stritt S, Kardonski P, Pulzer A. et al. Management of adrenal emergencies in educated patients with adrenal insufficiency-A prospective study. Clin Endocrinol (Oxf) 2018; 89: 22-9 Epub 2018/04/05 DOI: 10.1111/cen.13608 PubMed PMID: 29617051.
• 38 Kampmeyer D, Lehnert H, Moenig H. et al. Experience pays off! Endocrine centres are essential in the care of patients with adrenal insufficiency. Eur J Intern Med 2016; 35: e27-e28 Epub 2016/07/23 DOI: 10.1016/j.ejim.2016.07.008 PubMed PMID: 27444736.
• 39 Harbeck B, Brede S, Witt C. et al. Glucocorticoid replacement therapy in adrenal insufficiency--a challenge to physicians?. Endocr J. 2015; 62: 463-8 Epub 2015/03/06. DOI: 10.1507/endocrj.EJ14-0612. PubMed PMID: 25739727.
• 40 White KG. A retrospective analysis of adrenal crisis in steroid-dependent patients: causes, frequency and outcomes. BMC Endocr Disord 2019; 19: 129 Epub 2019/12/04 DOI: 10.1186/s12902-019-0459-z PubMed PMID: 31791297; PubMed Central PMCID: PMCPMC6889201.
• 41 Forss M, Batcheller G, Skrtic S. et al. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey. BMC Endocr Disord 2012; 12: 8. Epub 2012/06/15 DOI: 10.1186/1472-6823-12-8 PubMed PMID: 22695167; PubMed Central PMCID: PMCPMC3403959.
• 42 Tiemensma J, Andela CD, Pereira AM. et al. Patients with adrenal insufficiency hate their medication: concerns and stronger beliefs about the necessity of hydrocortisone intake are associated with more negative illness perceptions. J Clin Endocrinol Metab 2014; 99: 3668-76 Epub 2014/09/17 DOI: 10.1210/jc.2014-1527. PubMed PMID: 25226291.
• 43 Chapman SC, Llahana S, Carroll P. et al. Glucocorticoid therapy for adrenal insufficiency: nonadherence, concerns and dissatisfaction with information. Clin Endocrinol (Oxf) 2016; 84: 664-71 Epub 2015/12/08 DOI: 10.1111/cen.12991. PubMed PMID: 26641418.
• 44 Schofl C, Mayr B, Maison N. et al. Daily adjustment of glucocorticoids by patients with adrenal insufficiency. Clin Endocrinol (Oxf) 2019; 91: 256-62 Epub 2019/05/06 DOI: 10.1111/cen.14004. PubMed PMID: 31050815.
• 45 Guignat L. Therapeutic patient education in adrenal insufficiency. Ann Endocrinol (Paris) 2018; 79: 167-73 Epub 2018/04/03. DOI: 10.1016/j.ando.2018.03.002.PubMed PMID: 29606279.
• 46 Burger-Stritt S, Hahner S. [Adrenal Insufficiency]. Dtsch Med Wochenschr 2016; 141: 1740-2. Epub 2016/12/03. DOI: 10.1055/s-0042-118276.PubMed PMID: 27903023.
• 47 Repping-Wuts HJ, Stikkelbroeck NM, Noordzij A. et al. A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis. Eur J Endocrinol 2013; 169: 17-22 Epub 2013/05/03. DOI: 10.1530/eje-12-1094 PubMed PMID: 23636446.
• 48 Eff A, Burger-Stritt S, Quinkler M. Evaluation of a German-wide Education Programme For Patients With Adrenal Insufficiency – First Interim Analysis. Poster, DACH-Tagung München 2016; P01-P13
• 49 Fleming L, Knafl K, Knafl G. et al. Parental management of adrenal crisis in children with congenital adrenal hyperplasia. J Spec Pediatr Nurs 2017; 22: 4. Epub 2017/08/05 DOI: 10.1111/jspn.12190 PubMed PMID: 28771930; PubMed Central PMCID: PMCPMC5884098.
• 50 Meyer G, Koch M, Herrmann E. et al. Longitudinal AddiQoL scores may identify higher risk for adrenal crises in Addison's disease. Endocrine 2018; 60: 355-61. Epub 2018/02/02. DOI: 10.1007/s12020-017-1513-0 PubMed PMID: 29388043.
• 51 Arlt W, Baldeweg SE, Pearce SHS. et al. Endocrinology in the time of COVID-19: Management of adrenal insufficiency. Eur J Endocrinol 2020; Epub 2020/05/08. DOI: 10.1530/eje-20-0361 PubMed PMID: 32379699.
• 52 Kaiser UB, Mirmira RG, Stewart PM. Our Response to COVID-19 as Endocrinologists and Diabetologists. J Clin Endocrinol Metab 2020; 105: 5. Epub 2020/04/02 DOI: 10.1210/clinem/dgaa148. PubMed PMID: 32232480; PubMed Central PMCID: PMCPMC7108679.
• 53 Isidori AM, Pofi R, Hasenmajer V. et al. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection. Lancet Diabetes Endocrinol 2020; Epub 2020/04/27. DOI: 10.1016/s2213-8587(20)30149-2 PubMed PMID: 32334645; PubMed Central PMCID: PMCPMC7180011.
• 54 Block P, Hoffman M, Raabe IJ. et al. Social Network-Based Distancing Strategies to Flatten the COVID-19 Curve in a Post-Lockdown World. Nat Hum Behav 2020; 4: 588-596 DOI: 10.1038/s41562-020-0898-6. Epub 2020 Jun 4